• Benefits and Limitations of TKIs in Patients with Medullary Thyroid Cancer: A Systematic Review and Meta-Analysis 

      Efstathiadou Z.A., Tsentidis C., Bargiota A., Daraki V., Kotsa K., Ntali G., Papanastasiou L., Tigas S., Toulis K., Pazaitou-Panayiotou K., Alevizaki M. (2021)
      Introduction: Tyrosine kinase inhibitors (TKIs) have been used in patients with advanced medullary thyroid carcinoma (MTC); however, data on their effectiveness and safety are limited. The aim of this systematic review and ...
    • Oligometastasis and local ablation in the era of systemic targeted and immunotherapy 

      Mazzola R., Jereczek-Fossa B.A., Franceschini D., Tubin S., Filippi A.R., Tolia M., Lancia A., Minniti G., Corradini S., Arcangeli S., Scorsetti M., Alongi F. (2020)
      Background: During these last years, new agents have dramatically improved the survival of the metastatic patients. Oligometastases represent a continuous field of interest in which the integration of metastases-directed ...